Impact of the first month of Covid-19 lockdown on oncologic surgical activity in the Ile de France region university hospital otorhinolaryngology departments

Laccourreye, O.; Mirghani, Haïtham; Evrard, Diane; Bonnefont, Pierre; Brugel, L.; Tankéré, F.; Coste, A.; Barry, B.; Baujat, B.; Atallah, Sarah; Kania, Romain

doi:10.1016/j.anorl.2020.06.007

Cited by 28 publications

(37 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…While the absolute size difference may not appear clinically significant, these measurements do not account for invasion into structures that may make treatment more morbid and therefore should not be discounted. These findings are similarly reflected in the study by Laccourreye et al, 26 who reported a higher proportion of surgeries performed on T3/4 and N2/3 tumors during the COVID‐19 pandemic compared to the preceding months.…”

Section: Discussionsupporting

confidence: 80%

The impact of COVID‐19 on head and neck cancer diagnosis and disease extent

et al. 2021

View full text Add to dashboard Cite

Background Due to COVID‐19, diagnostic delays and a surge of advanced head and neck cancer (HNC) is anticipated. We hereby evaluate patient and tumor characteristics before and during the early COVID‐19 period. Methods Retrospective review of patients with HNC presented at a multidisciplinary tumor conference from May 14, 2020 to June 18, 2020 was performed and compared to a similar 6‐week period a year before. Demographics, time to diagnosis, and tumor characteristics were analyzed. Results There was a 25% reduction in newly diagnosed malignancies. Groups were similar in baseline characteristics, duration of symptoms, and time to diagnosis. However, median primary tumor size was significantly larger ( p = 0.042) and T stage more advanced for mucosal subsites ( p = 0.025) in the COVID‐19 group. Conclusion Our findings suggest increased tumor burden in patients with HNC presenting during the pandemic, despite a similar time to diagnosis. This may become more pronounced as the pandemic duration is extended.

show abstract

Section: Discussionsupporting

confidence: 80%

The impact of COVID‐19 on head and neck cancer diagnosis and disease extent

et al. 2021

View full text Add to dashboard Cite

show abstract

“…No patients developed clinical symptoms in hospital or on returning home. These findings are in agreement with those of Laccourreye et al [11] , who validated this hospital strategy for patients requiring prompt surgery.…”

Section: Discussionsupporting

confidence: 92%

Surgery under COVID: An observational study

Durand

Mirghani

Bonfils

et al. 2022

European Annals of Otorhinolaryngology, Head and Neck Diseases

Self Cite

View full text Add to dashboard Cite

Aim To evaluate the surgery program strategy adopted in an adult otorhinolaryngology and head and neck surgery department in an area badly affected by the Covid-19 epidemic peak. The main objective was to analyze the reasons for not cancelling surgeries and the postoperative course of operated patients. The secondary objective was to assess the situation of postponed patients. Material and Methods A single-center observational study carried out during the COVID-19 period in France included 124 patients scheduled for surgery during the period March 21-May 20, 2020. The number and nature of operations, both performed and postponed, were reviewed. Results A total of 54.0% patients were operated on during the COVID period and 46.0% were postponed. Operations were maintained in urgent or semi-urgent cases. The operated patients did not show any signs of infection during their hospital stay. A total of 29.8% of postponed patients were lost to follow-up and 49.1% were rescheduled. Conclusion The application of national and international recommendations minimized the risk of loss of chance for operated patients without increasing the risk of contamination. The postponement of canceled operations resulted in considerable loss to follow-up. Intensified follow-up is necessary for these patients.

show abstract

“…Methodological quality assessment of the included studies and reasons for judgment are presented in the Data Supplement. The methodological quality was considered low for case series, 43 , 45 low for longitudinal studies, 47 , 70 , 80 and moderate 2 , 48 , 75 to low 56 , 93 for cross-sectional studies.…”

Section: Resultsmentioning

confidence: 99%

Delays and Disruptions in Cancer Health Care Due to COVID-19 Pandemic: Systematic Review

Riera

Bagattini

Pacheco

et al. 2021

JCO Global Oncology

339

304

View full text Add to dashboard Cite

PURPOSE There has been noteworthy concern about the impact of COVID-19 pandemic on health services including the management of cancer. In addition to being considered at higher risk for worse outcomes from COVID-19, people with cancer may also experience disruptions or delays in health services. This systematic review aimed to identify the delays and disruptions to cancer services globally. METHODS This is a systematic review with a comprehensive search including specific and general databases. We considered any observational longitudinal and cross-sectional study design. The selection, data extraction, and methodological assessment were performed by two independent reviewers. The methodological quality of the studies was assessed by specific tools. The delays and disruptions identified were categorized, and their frequency was presented. RESULTS Among the 62 studies identified, none exhibited high methodological quality. The most frequent determinants for disruptions were provider- or system-related, mainly because of the reduction in service availability. The studies identified 38 different categories of delays and disruptions with impact on treatment, diagnosis, or general health service. Delays or disruptions most investigated included reduction in routine activity of cancer services and number of cancer surgeries; delay in radiotherapy; and delay, reschedule, or cancellation of outpatient visits. Interruptions and disruptions largely affected facilities (up to 77.5%), supply chain (up to 79%), and personnel availability (up to 60%). CONCLUSION The remarkable frequency of delays and disruptions in health care mostly related to the reduction of the COVID-19 burden unintentionally posed a major risk on cancer care worldwide. Strategies can be proposed not only to mitigate the main delays and disruptions but also to standardize their measurement and reporting. As a high number of publications continuously are being published, it is critical to harmonize the upcoming reports and constantly update this review.

show abstract

Impact of the first month of Covid-19 lockdown on oncologic surgical activity in the Ile de France region university hospital otorhinolaryngology departments

Cited by 28 publications

References 22 publications

The impact of COVID‐19 on head and neck cancer diagnosis and disease extent

The impact of COVID‐19 on head and neck cancer diagnosis and disease extent

Surgery under COVID: An observational study

Delays and Disruptions in Cancer Health Care Due to COVID-19 Pandemic: Systematic Review

Contact Info

Product

Resources

About